Siga Technologies Inc.

SIGA Healthcare Drug Manufacturers Specialty & Generic

Siga Technologies Inc.’s revenue for fiscal 2025 (year ended December 2025) was $94.6 million, down 31.8% from fiscal 2024. In the quarter to June 2026, revenue fell 49.5%, EPS fell 66.0% and free cash flow fell 76.0%, each against the same quarter a year earlier. Dividend growth for five consecutive years.

3.17 0.02 −0.63%
Market cap
$229.2M
P/E
0.0×
Fwd P/E
28.7×
Dividend yield
0.00%
F-score
5/9
Altman Z
14.28
Beneish M
−4.02
Dividend safety
36/100
Older periods Sep '25 Dec '25 Mar '26 Jun '26
P/E ratio

+8 more quarters

8.85 18.28 18.45 0.00
P/S ratio
3.80 4.62 4.09 4.87
P/FCF ratio
5.63 10.14 13.99 0.00
P/Operating CF
(66.76) (25.92) (44.24) 17.21
P/B ratio
3.22 2.20 2.53 1.58
Price to Tangible BV
3.23 2.21 2.54 1.59
EV/Sales
3.73 4.66 4.23 5.64
EV/EBITDA
7.07 18.18 18.70 0.00
EV/Operating CF
5.51 10.15 14.30 (15.00)
EV/FCF
5.52 10.23 14.48 (14.74)
Quick Ratio
7.02 8.79 2.30 15.90
Current Ratio
9.17 11.83 3.25 21.72
Net Debt/EBITDA
17.06 16.57 28.15 (8.36)
Debt/Assets
0.00% 0.00% 0.00% 0.00%
Debt/Equity
0.00 0.00 0.00 0.00
Asset Turnover
0.81 0.41 0.40 0.26
Operating CF/Net income
1.54 3.11 2.51 1.22
Capex/Depreciation
(2.04) (0.28) 0.00 0.00
Research and Development Expense of Revenue
269.24% 132.87% 63.27% 10.70%
Selling, General and Administrative Expense of Revenue
182.69% 138.71% 74.86% 12.56%
Intangible Assets out of Total Assets
0.00 0.00 0.00 0.01
Share Based Compensation of Revenue
29.55% 20.36% 12.06% 2.95%
Graham Net Nets
0.30 0.44 0.38 0.61
Graham Number
8.13 4.57 3.72 0.00
Earnings Yield
11.30% 5.47% 5.42% (1.10%)
Free Cash Flow Yield
17.75% 9.87% 7.15% (7.86%)
Revenue per Share
0.04 0.05 0.09 0.57
Operating CF per Share
(0.14) (0.24) (0.12) 0.21
Capex per Share
0.00 0.00 0.00 0.00
Free Cash Flow per Share
(0.14) (0.24) (0.12) 0.21
Cash per Share
2.40 2.17 2.03 1.64
Shareholders Equity per Share
2.84 2.78 2.12 2.30
Interest Debt per Share
0.00 0.00 0.00 0.00
Book value per Share
2.84 2.78 2.12 2.30
Free Cash Flow
(10.10) (16.90) (8.66) 15.17
Working Capital
202.90 194.86 146.37 162.53
Capital Expenditures
(0.29) (0.04) — —
Net Current Asset Value
199.62 192.21 143.76 159.93
EV/EBIT
7.11 18.61 19.22 0.00
Capex to Sales
0.11 0.01 0.00 0.00
Price to Operating Income
7.26 18.44 18.58 0.00
Other line items
Average Receivables
7.29 12.21 5.84 6.83
Average Payables
3.15 1.08 3.77 1.05
Average Inventory
55.02 49.31 57.78 38.36
Average Assets
213.48 231.90 233.23 205.53
Average Common Equity
186.46 207.31 183.88 187.30

Fold the line items

Columns are period end dates